Abstract

Awareness of deep venous thrombosis has increased considerably in the last decade including recognition of the importance of thromboprophylaxis for acutely ill hospital inpatients as preventative therapy. Combinations of a pre-test probability score plus a D-Dimer analysis can identify those patients where the chances of DVT are very low and radiological investigation can be obviated. The gold standard for diagnosis is still either ascending venography or venous Doppler ultrasound. Low molecular weight heparin has taken over from unfractionated calcium heparin as the initial treatment of choice. There are many challenges in management, especially deciding the optimum duration of anticoagulant treatment in order to balance the risks of drug induced bleeding against recurrent venous thromboembolic events.
[download-attachments container="div" style="list" dipslay_icon="1" display_count="1" display__size="0"]

References

1. Kiladjian JJ, Cervantes F, Leebeek FW et al. The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases. Blood. 2008 May 15; 111(10): 4922–4929.
2. D’Angelo A, D’Alessandro G, Tomassini L et al. Evaluation of a new rapid qualitative d-dimer assay in patients with clinically suspected deep venous thrombosis. Thrombosis and Haemostasis 1996; 75: 412–416.
3. Stricker H, Marchetti O, Harberli A et al. Haemostatic activation under anticoagulant treatment : a comparison of unfractionated heparin versus nadroparin in the treatment of proximal deep vein thrombosis. Thrombosis Haemostasis 1999; 82: 1227–1231.
4. Yamaki T, Nozaki M, Sakurai H et al. Prospective evaluation of a screening protocol to exclude deep vein thrombosis on the basis of a combination n of a quantitative D-dimer testing and pretest clinical probability score. Journal of American College of Surgeons 2005; 201, 5: 701–709.
5. Kearon C, Ginsberg JS, Douketis J et al. Management of suspected deep venous thrombosis in outpatients by using clinical assessment and d-dimer testing. Annals Internal Medicine 2001; 135: 98–107.
6. Janes S, Ashford N. Use of a simplified clinical scoring system and DDimer testing can reduce the requirement for radiology in the exclusion of deep vein thrombosis by over 20%. British Journal of Haematology 2001; 112: 1079–1082.
7. Paneesha S, Cheyne E, French K et al. High D-Dimer levels at presentation in patients with venous thromboembolism is a marker of adverse clinical outcomes (2006). British Journal of Haematology ;135: 85–90.
8. Harenberg J, Riess H, Buller HR et al. Comparison of six month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body weight adjusted dosage or unfractionated heparin. Haematologica 2003; 88, 10: 1157– 1162.
9. Hull RD, Raskob GE, Rosenbloom D et al. Heparin for 5 days as compared with 10 days in the initial management of proximal venous thrombosis. New England Journal of Medicine 1990; 332: 1260–1264.
10. Hull RD, Pineo GF, Brant RF et al. Long-term low molecular weight heparin versus usual care in proximal vein thrombosis patients with cancer. American Journal of Medicine 2006; 119(12): 1062–1072.
11. Van Dongen CJ, van den Belt AG, Prins MH et al. Fixed dose low molecular weight heparin versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Systemic Review 2004; 18(4): CD001100.
12. Kearon C, Ginsberg JS, Julian JA et al. Comparison of fixed dose weight adjusted unfractionated heparin and low molecular weight heparin for acute treatment of venous thromboembolism. Journal of American Medical Physicians 2006; 296 (8): 935–942.
13. Buller HR, Davidson BL, Decousus H et al. Fondaparinux or enoxaparinfor the initial treatment of symptomatic deep venous thrombosis. Annals of internal medicine 2004; 140 (11): 867–873
14. Partsch H. Ambulation and compression after deep vein thrombosis : dispelling myths. Seminars in vascular surgery 2005; 18 (3): 148–152.
15. Junger M, Diehm C, Storiko H et al. Mobilisation versus immobilisation in the treatment of acute proximal deep venous thrombosis : a prospective, randomised, open, multicentre trial. Current Medical Research Opinion 2006; 22(3): 593–602.